Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Inhibition of beta-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure-activity relationship with a strong BBB permeability - Jannat_2019_Exp.Mol.Med_51_12 |
| Author(s) : Jannat S , Balupuri A , Ali MY , Hong SS , Choi CW , Choi YH , Ku JM , Kim WJ , Leem JY , Kim JE , Shrestha AC , Ham HN , Lee KH , Kim DM , Kang NS , Park GH |
| Ref : Exp Mol Med , 51 :12 , 2019 |
| Abstract : Jannat_2019_Exp.Mol.Med_51_12 |
| ESTHER : Jannat_2019_Exp.Mol.Med_51_12 |
| PubMedSearch : Jannat_2019_Exp.Mol.Med_51_12 |
| PubMedID: 30755593 |
| Title : Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exercise - Park_2017_Diabetes.Obes.Metab_19_1681 |
| Author(s) : Park J , Park SW , Yoon KH , Kim SR , Ahn KJ , Lee JH , Mok JO , Chung CH , Han KA , Koh GP , Kang JG , Lee CB , Kim SH , Kwon NY , Kim DM |
| Ref : Diabetes Obes Metab , 19 :1681 , 2017 |
| Abstract : Park_2017_Diabetes.Obes.Metab_19_1681 |
| ESTHER : Park_2017_Diabetes.Obes.Metab_19_1681 |
| PubMedSearch : Park_2017_Diabetes.Obes.Metab_19_1681 |
| PubMedID: 28448688 |
| Title : A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naive patients with type 2 diabetes - Yang_2015_Endocr.J_62_449 |
| Author(s) : Yang HK , Min KW , Park SW , Chung CH , Park KS , Choi SH , Song KH , Kim DM , Lee MK , Sung YA , Baik SH , Kim IJ , Cha BS , Park JH , Ahn YB , Lee IK , Yoo SJ , Kim J , Park Ie B , Park TS , Yoon KH |
| Ref : Endocrine Journal , 62 :449 , 2015 |
| Abstract : Yang_2015_Endocr.J_62_449 |
| ESTHER : Yang_2015_Endocr.J_62_449 |
| PubMedSearch : Yang_2015_Endocr.J_62_449 |
| PubMedID: 25819061 |
| Title : Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension - Jin_2015_Diabetes.Obes.Metab_17_511 |
| Author(s) : Jin SM , Park SW , Yoon KH , Min KW , Song KH , Park KS , Park JY , Park IB , Chung CH , Baik SH , Choi SH , Lee HW , Lee IK , Kim DM , Lee MK |
| Ref : Diabetes Obes Metab , 17 :511 , 2015 |
| Abstract : Jin_2015_Diabetes.Obes.Metab_17_511 |
| ESTHER : Jin_2015_Diabetes.Obes.Metab_17_511 |
| PubMedSearch : Jin_2015_Diabetes.Obes.Metab_17_511 |
| PubMedID: 25523633 |
| Title : A lactate-induced response to hypoxia - Lee_2015_Cell_161_595 |
| Author(s) : Lee DC , Sohn HA , Park ZY , Oh S , Kang YK , Lee KM , Kang M , Jang YJ , Yang SJ , Hong YK , Noh H , Kim JA , Kim DJ , Bae KH , Kim DM , Chung SJ , Yoo HS , Yu DY , Park KC , Yeom YI |
| Ref : Cell , 161 :595 , 2015 |
| Abstract : Lee_2015_Cell_161_595 |
| ESTHER : Lee_2015_Cell_161_595 |
| PubMedSearch : Lee_2015_Cell_161_595 |
| PubMedID: 25892225 |
| Title : Expression of functional Candida antarctica lipase B in a cell-free protein synthesis system derived from Escherichia coli - Park_2009_Biotechnol.Prog_25_589 |
| Author(s) : Park CG , Kim TW , Oh IS , Song JK , Kim DM |
| Ref : Biotechnol Prog , 25 :589 , 2009 |
| Abstract : Park_2009_Biotechnol.Prog_25_589 |
| ESTHER : Park_2009_Biotechnol.Prog_25_589 |
| PubMedSearch : Park_2009_Biotechnol.Prog_25_589 |
| PubMedID: 19294752 |